The acquisition of Helvoet for €90 million enhances medical manufacturing capabilities, expands geographic reach in Europe and India, and is expected to be accretive to earnings by fiscal 2027. The deal strengthens the competitive position in high-growth healthcare segments.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.